Effects of oxysterols on the blood-brain barrier: Implications for Alzheimer's disease

被引:52
|
作者
Gosselet, Fabien
Saint-Pol, Julien
Fenart, Laurence
机构
[1] Univ Lille Nord France, Lille, France
[2] UArtois, LBHE, EA 2465, Lens, France
[3] IMPRT IFR114, Lille, France
关键词
Oxysterols; Blood-brain barrier; ABCA1; ABCB1; Alzheimer's disease; LXR; CAPILLARY ENDOTHELIAL-CELLS; AMYLOID-BETA-PEPTIDE; BODY CHOLESTEROL METABOLISM; TO-BASOLATERAL TRANSPORT; TRANSGENIC MOUSE MODEL; P-GLYCOPROTEIN; IN-VITRO; APOLIPOPROTEIN-E; A-BETA; NEURODEGENERATIVE DISEASES;
D O I
10.1016/j.bbrc.2013.11.059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Altered brain cholesterol homeostasis plays a key role in neurodegenerative diseases such as Alzheimer's disease (AD). For a long time, the blood-brain barrier (BBB) was basically considered as a barrier isolating the brain from circulating cholesterol, however, several lines of evidence now suggest that the BBB strictly regulates the exchanges of sterol between the brain and the peripheral circulation. Oxysterols, synthesized by neurons or by peripheral cells, cross the BBB easily and modulate the expression of several enzymes, receptors and transporters which are involved not only in cholesterol metabolism but also in other brain functions. This review article deals with the way oxysterols impact BBB cells. These perspectives open new routes for designing certain therapeutical approaches that target the BBB so that the onset and/or progression of brain diseases such as AD may be modulated. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:687 / 691
页数:5
相关论文
共 50 条
  • [21] Transport of drugs across the blood-brain barrier in Alzheimer's disease
    Nicolazzo, Joseph A.
    Mehta, Dharmini C.
    THERAPEUTIC DELIVERY, 2010, 1 (04) : 595 - 611
  • [22] Dyslipidemia in Alzheimer's Disease Is Associated with Blood-Brain Barrier Impairment
    Bowman, Gene L.
    Kaye, Jeffery A.
    Quinn, Joseph F.
    NEUROLOGY, 2010, 74 (09) : A137 - A137
  • [23] Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease
    Bell, Robert D.
    Zlokovic, Berislav V.
    ACTA NEUROPATHOLOGICA, 2009, 118 (01) : 103 - 113
  • [24] Alzheimer's disease: future drug development and the blood-brain barrier
    Pardridge, William M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (07) : 569 - 572
  • [25] Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
    Gosselet, Fabien
    Saint-Pol, Julien
    Candela, Pietra
    Fenart, Laurence
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (10) : 1015 - 1033
  • [26] Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease
    Erickson, Michelle A.
    Banks, William A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2013, 33 (10): : 1500 - 1513
  • [27] Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer's Disease
    Rezai, Ali R.
    D'Haese, Pierre-Francois
    Finomore, Victor
    Carpenter, Jeffrey
    Ranjan, Manish
    Wilhelmsen, Kirk
    Mehta, Rashi I.
    Wang, Peng
    Najib, Umer
    Teixeira, Camila Vieira Ligo
    Arsiwala, Tasneem
    Tarabishy, Abdul
    Tirumalai, Padmashree
    Claassen, Daniel O.
    Hodder, Sally
    Haut, Marc W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (01): : 55 - 62
  • [28] Microvascular injury and blood-brain barrier leakage in Alzheimer's disease
    Zipser, B. D.
    Johanson, C. E.
    Gonzalez, L.
    Berzin, T. M.
    Tavares, R.
    Hulette, C. M.
    Vitek, M. P.
    Hovanesian, V.
    Stopa, E. G.
    NEUROBIOLOGY OF AGING, 2007, 28 (07) : 977 - 986
  • [29] Treatment of Alzheimer's Disease and Blood-Brain Barrier Drug Delivery
    Pardridge, William M.
    PHARMACEUTICALS, 2020, 13 (11) : 1 - 25
  • [30] Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease
    Simic, Goran
    Spanic, Ena
    Horvat, Lea Langer
    Hof, Patrick R.
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT A, 2019, 168 : 99 - 145